Our findings suggest that IFN-γ exposure to low-IFN GSCs promoted a mesenchymal phenotype in GSCs, which might contribute to an aggressive phenotype, as is observed in recurrent GBM. The gene discussed is IFNG; the disease is glioblastoma.